Macrogen

Macrogen Interest Coverage

The Interest Coverage Ratio of Macrogen (038290.KQ) as of Oct 29, 2026 is -11.92. In the previous year, Interest Coverage Ratio was 0.14 — a change of -8,817.48% (lower).

Interest Coverage

-11.92

YoY

-8,817.48%

Last updated:

Interest Coverage Ratio of Macrogen is 2024 -11.92 . Interest Coverage Ratio of Macrogen was 2023 0.14 . It decreases by -8,817.48% lower compared to the previous year.

The Macrogen Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2015
3.19 KRW
Jan 1, 2016
3.95 KRW
Jan 1, 2017
0.29 KRW
Jan 1, 2018
0.55 KRW
Jan 1, 2019
0.43 KRW
Jan 1, 2020
8.52 KRW
Jan 1, 2021
0.14 KRW
Jan 1, 2024
-11.92 KRW
The Macrogen Interest Coverage history
YEARInterest CoverageYoY
-11.92-8,817.48%
0.14-98.39%
8.52+1,873.77%
0.43-22.08%
0.55+89.22%
0.29-92.60%
3.95+23.90%
3.19-99.63%
866.85—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Macrogen Stock analysis

What does Macrogen do? Macrogen Inc. generates revenue through its four business divisions. The DNA sequencing division provides genome sequencing analysis services to clients requiring genetic data processing. The DNA chips division sells products including Illumina chips, MacArray chips, and customized chips to research institutions and biotech firms. The transgenic and knockout mouse division offers gene engineering services to pharmaceutical companies and academic laboratories. The oligonucleotide DNA division supplies oligonucleotide DNA manufacturing services to biotechnology clients. All services are delivered domestically and internationally to established market segments. The company's DNA chips division markets specific branded products like Illumina chips and MacArray chips, which are purchased by research organizations and biotechnology enterprises. Gene engineering services from the transgenic division are bought by pharmaceutical companies seeking to develop new treatments. Oligonucleotide DNA manufacturing services target biotech clients needing specialized DNA synthesis. Domestic and overseas markets represent the primary customer segments for all divisions. Macrogen's product portfolio includes DNA sequencing services, DNA chip products, gene engineering solutions, and oligonucleotide DNA manufacturing. Clients include research institutions, pharmaceutical companies, academic laboratories, and biotechnology firms. The DNA chips division's branded products are specifically named in the description, while other services are described by their technical functions. Market segments are defined by the company's domestic and international operations. Macrogen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Macrogen stock

Interest Coverage Ratio of Macrogen is -11.92 in 2024.

Interest Coverage Ratio of Macrogen changed from 0.14 to -11.92, representing a -8,817.48% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Macrogen since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Macrogen with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Macrogen

All Key Metrics — Macrogen